The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity

Table 3

List of antibodies used in the study.

Antibodies	Concentrations	CAT numbers	Company
β-Actin	1 : 1000	a5441	Sigma
Il-4	1 : 1000	AF5142	Affinity biosciences
Il-6	1 : 1000	ab6672	Abcam
IL-10	1 : 1000	DF6894	Affinity biosciences
MCP-1	1 : 1000	AF5330	Affinity biosciences
MMP-2	1 : 1000	AF5330	Affinity biosciences
MMP-9	1 : 1000	HPA001238	Sigma
MMP-13	1 : 1000	AF5355	Affinity biosciences
MMP-14	1 : 1000	AF0212	Affinity biosciences
Glut-2	1 : 1000	orb10726	Biorbyt

Β-Actin: beta-actin; IL-4: interleukin 4; IL-6: interleukin 6; IL-10: interleukin 10; MCP-1: chemokine (C-C Motif) ligand 2 (CCL2); MMP-2: matrix metallopeptidase 2; MMP-9: matrix metallopeptidase 9; MMP-13: matrix metallopeptidase 13; MMP-14: matrix metallopeptidase 14; Glut-2: glucose transporter 2.